GMP Beta-Amyloid (1-42), human

Aß (1-42), a major component of amyloid plaques, accumulates in neurons of Alzheimer’s disease brains. Biochemical analysis of the amyloid peptides isolated from Alzheimer’s disease brain indicates that Aß (1-42) is the principal species associated with senile plaque amyloids, while Aß (1-40) is more abundant in cerebrovascular amyloid deposit.
This cGMP beta-Amyloid 1-42 peptide has been produced under conditions compliant with 21 CFR part 820 & ISO 13485 and is appropriate for use as an IVD component or as a quality control standard (not for human use).

QC attributes

Peptide Purity: =95%

Endotoxin: =1 EU/mg

Bioburden: Report Results (Lot specific)

Solubility: Aqueous media (see CoA)

Monomer content: =95%

Specifications

Downloads